Stock price for Inj exhibits potential breakthrough signs heading toward the $8 mark, following the breakdown of its triangular pattern.

In the dynamic world of cryptocurrency, Injective (INJ) has made a significant move. The digital asset, known for its prominence in the market, has recently broken out from an ascending triangle, a potential indicator of downside toward $8 according to market chart analysis.

The breakout occurred on September 1, 2025, with INJ trading at $12.49 after a 1.56% drop in the previous session. This move has invalidated the previous bullish structure, and traders are now assessing downside potential using Fibonacci retracement levels.

The Fibonacci chart highlights several levels between $13.33 at 0.236 and $8.29 at 0.786, offering potential areas for price reaction. Analysts most likely target the Fibonacci level around 0.618 (61.8%) for INJ under the current situation, with the current price approaching or testing this key retracement level, which often acts as strong support or resistance in technical analysis.

A deeper move toward $8.29 at 0.786 would confirm the bearish projection. However, analysts suggest that each level may provide temporary support, but the trend remains vulnerable following the triangle failure. Another potential test is $9.51 at 0.618, before the price reaches the $8.29 mark.

The immediate pressure places the token between $11.46 at 0.382 and $10.52, a psychological mark where buying interest may re-emerge due to its significance. The 0.5 retracement aligns at $10.52.

Even amid corrections, the broader project structure remains intact according to some traders. The triangle break is seen as clean and decisive by some, indicating a clear shift in market sentiment. The outcome of this move could shape sentiment across related decentralized finance markets.

The post about Injective (INJ) attracted significant engagement with over 13,800 views and numerous comments, reflecting the interest and concern of the cryptocurrency community. As always, traders are advised to balance risk management with expectations of volatility, and to make informed decisions based on their own research and analysis.